German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management
- PMID: 30306295
- DOI: 10.1007/s00392-018-1377-1
German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management
Abstract
Cardiac arrhythmias remain a common challenge and are associated with significant morbidity and mortality. Effective and safe rhythm control strategies are a primary, yet unmet need in everyday clinical practice. Despite significant pharmacological and technological advances, including catheter ablation and device-based therapies, the development of more effective alternatives is of significant interest to increase quality of life and to reduce symptom burden, hospitalizations and mortality. The mechanistic understanding of pathophysiological pathways underlying cardiac arrhythmias has advanced profoundly, opening up novel avenues for mechanism-based therapeutic approaches. Current management of arrhythmias, however, is primarily guided by clinical and demographic characteristics of patient groups as opposed to individual, patient-specific mechanisms and pheno-/genotyping. With this state-of-the-art paper, the Working Group on Cellular Electrophysiology of the German Cardiac Society aims to close the gap between advanced molecular understanding and clinical decision-making in cardiac electrophysiology. The significance of cellular electrophysiological findings for clinical arrhythmia management constitutes the main focus of this document. Clinically relevant knowledge of pathophysiological pathways of arrhythmias and cellular mechanisms of antiarrhythmic interventions are summarized. Furthermore, the specific molecular background for the initiation and perpetuation of atrial and ventricular arrhythmias and mechanism-based strategies for therapeutic interventions are highlighted. Current "hot topics" in atrial fibrillation are critically appraised. Finally, the establishment and support of cellular and translational electrophysiology programs in clinical rhythmology departments is called for to improve basic-science-guided patient management.
Keywords: Antiarrhythmic therapy; Arrhythmogenesis; Cellular electrophysiology; Ion channels; Pathophysiology.
Similar articles
-
Genetic polymorphisms and arrhythmia susceptibility.Circ J. 2007;71 Suppl A:A54-60. doi: 10.1253/circj.71.a54. Circ J. 2007. PMID: 17587741 Review.
-
Modernized Classification of Cardiac Antiarrhythmic Drugs.Circulation. 2018 Oct 23;138(17):1879-1896. doi: 10.1161/CIRCULATIONAHA.118.035455. Circulation. 2018. PMID: 30354657
-
Update on antiarrhythmic drug pharmacology.J Cardiovasc Electrophysiol. 2020 Feb;31(2):579-592. doi: 10.1111/jce.14347. Epub 2020 Jan 22. J Cardiovasc Electrophysiol. 2020. PMID: 31930579 Review.
-
["Sicilian gambit": pathophysiological approach to drug therapy of arrhythmia (lecture]].Ter Arkh. 1999;71(8):67-74. Ter Arkh. 1999. PMID: 10515042 Russian. No abstract available.
-
Ranolazine in Cardiac Arrhythmia.Clin Cardiol. 2016 Mar;39(3):170-8. doi: 10.1002/clc.22476. Epub 2015 Oct 13. Clin Cardiol. 2016. PMID: 26459200 Free PMC article. Review.
Cited by
-
Increased in vivo perpetuation of whole-heart ventricular arrhythmia in heterozygous Na+/Ca2+ exchanger knockout mice.Int J Cardiol Heart Vasc. 2022 Dec 30;44:101168. doi: 10.1016/j.ijcha.2022.101168. eCollection 2023 Feb. Int J Cardiol Heart Vasc. 2022. PMID: 36620202 Free PMC article.
-
Prognostic impact of recurrences of ventricular tachyarrhythmias and appropriate ICD therapies in a high-risk ICD population.Clin Res Cardiol. 2019 Aug;108(8):878-891. doi: 10.1007/s00392-019-01416-y. Epub 2019 Feb 12. Clin Res Cardiol. 2019. PMID: 30756152
-
The role of β-catenin in cardiac diseases.Front Pharmacol. 2023 Mar 22;14:1157043. doi: 10.3389/fphar.2023.1157043. eCollection 2023. Front Pharmacol. 2023. PMID: 37033656 Free PMC article. Review.
-
Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development.Cardiovasc Res. 2023 Dec 19;119(16):2623-2637. doi: 10.1093/cvr/cvad143. Cardiovasc Res. 2023. PMID: 37677054 Free PMC article.
-
Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications.Nat Rev Cardiol. 2024 Oct;21(10):682-700. doi: 10.1038/s41569-024-01038-6. Epub 2024 May 30. Nat Rev Cardiol. 2024. PMID: 38816507 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
- Josef Freitag Foundation/Deutsche Stiftung für Herzforschung
- F/08/14/Deutsche Stiftung für Herzforschung
- F/03/15/Deutsche Stiftung für Herzforschung
- 2014_A242/Else Kröner-Fresenius-Stiftung
- 2014_A306/Else Kröner-Fresenius-Stiftung
- 2016_A20/Else Kröner-Fresenius-Stiftung
- TH1120/7-1/Deutsche Forschungsgemeinschaft
- TH1120/8-1/Deutsche Forschungsgemeinschaft
- KFO196/Deutsche Forschungsgemeinschaft
- BR2107/4-1/Deutsche Forschungsgemeinschaft
- OD86/6/Deutsche Forschungsgemeinschaft
- VO1568/3-1/Deutsche Forschungsgemeinschaft
- IRTG1816 RP12/Deutsche Forschungsgemeinschaft
- SFB1002 TPA13/Deutsche Forschungsgemeinschaft
- SCHW 1611/1-1/Deutsche Forschungsgemeinschaft
- Sonderlinie Medizin/Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg
- Wrangell Programm/Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg
- DGK0914/Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.
- EUTRAG/European Union Seventh Framework Programme
- EUTRAF/European Union Seventh Framework Programme
- ZonMW Veni 91616057/Netherlands Organization for Scientific Research
- PREDICT/Netherlands Heart Foundation
- Beacon Research Fellowship/University of Adelaide
- Senior Career Fellowship/Molecular Medicine Partnership Unit, Heidelberg
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous